VoxNeuro’s Cognitive Health Assessments™ will be used alongside blood tests and various behavioural and clinical assessments to identify biomarkers of bipolar disorder.

VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, has reported that the Phase 3 study of its trivalent hepatitis B vaccine has met both primary and secondary endpoints for safety and efficacy.

The Trade Commissioner Service is currently recruiting for the Canadian Technology Accelerator cohort for life sciences start-ups and companies seeking to expand in the US and Asia.

Toronto-based Deep Genomics, which has developed a platform that uses deep learning to create therapies, has closed a $40 million Series B round.

ProteinQure, which has designed a platform to automate the computational design of protein-based drugs, has been named one of CB Insights’ Game Changers for 2020.

Synaptive Medical, a Toronto-based medical and technology company solving surgical, imaging and data challenges, has completed a first round of investment totaling $25,000,000 USD.

iMerciv was accepted into the Fall 2019 Cohort of the Canadian Technology Accelerator in Silicon Valley, which helps high-potential Canadian technology companies access the unique resources of Silicon Valley to grow at a global scale.

Profound Medical announced that they have received 510(k) clearance from the U.S. Food and Drug Administration to market TULSA-PRO® for ablation of prostate tissue.

Able Innovations will be pitching live against 9 other companies for a chance to win up to $75,000 in cash prizes at the Lions Lair.

Perimeter Medical Imaging announce the completion of a pre-public financing round raising $C4.4million.

Hosted by Sunnybrook, this flagship weekly lecture series features enlightening talks on key topics related to pursuing medical technology innovation, commercialization and entrepreneurship, aimed at clinicians, engineers and life sciences researchers and trainees.

The Women Founders Fund aims to bridge the gap on entrepreneurial equal opportunity by providing access to resources and empowering growth for female entrepreneurs.

The RBC Post-Doctoral & Graduate Fellowships will support research and innovation at the University of Toronto and recognize emerging leaders who are establishing a record of research, scholarship, and impact, and exhibit the potential to make significant contributions to the body of research in the field of entrepreneurship and innovation.

Founded in 2014, 43North is a startup competition with prizes of $5M USD in investment, dedicated mentorship and free incubator space in Buffalo, NY.

Steadiwear announced that they received FDA registration and that the Steadi-One is now available for pre-order.